A detailed history of D. E. Shaw & Co., Inc. transactions in Pfizer Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 11,881,400 shares of PFE stock, worth $326 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
11,881,400
Previous 12,307,600 3.46%
Holding current value
$326 Million
Previous $342 Million 2.66%
% of portfolio
0.34%
Previous 0.3%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $401 Million - $470 Million
-15,868,198 Reduced 65.32%
8,424,721 $236 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $253 Million - $290 Million
9,770,933 Added 67.28%
24,292,919 $674 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $35.8 Million - $46.5 Million
1,369,112 Added 10.41%
14,521,986 $418 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $214 Million - $250 Million
6,675,541 Added 103.06%
13,152,874 $436 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $41.2 Million - $47.7 Million
-1,141,180 Reduced 14.98%
6,477,333 $238 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $14.2 Million - $18.5 Million
361,509 Added 4.98%
7,618,513 $311 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $184 Million - $240 Million
4,402,503 Added 154.23%
7,257,004 $372 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.21 Million - $1.47 Million
-27,604 Reduced 0.96%
2,854,501 $125 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $324 Million - $385 Million
-6,973,010 Reduced 70.76%
2,882,105 $151 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $299 Million - $370 Million
6,533,107 Added 196.66%
9,855,115 $510 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $48 Million - $71.1 Million
-1,160,547 Reduced 25.89%
3,322,008 $196 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $60.5 Million - $77.7 Million
-1,541,261 Reduced 25.59%
4,482,555 $193 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $164 Million - $186 Million
4,572,946 Added 315.19%
6,023,816 $236 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $10 Million - $11.3 Million
-299,828 Reduced 17.13%
1,450,870 $52.6 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $144 Million - $183 Million
-4,306,383 Reduced 71.1%
1,750,698 $64.4 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $117 Million - $138 Million
-3,694,687 Reduced 37.89%
6,057,081 $222 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $60.1 Million - $72.9 Million
-1,995,164 Reduced 16.98%
9,751,768 $319 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $225 Million - $322 Million
8,338,430 Added 244.64%
11,746,932 $383 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $4.47 Million - $5.07 Million
135,707 Added 4.15%
3,408,502 $134 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $8.99 Million - $11.7 Million
-276,769 Reduced 7.8%
3,272,795 $118 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $270 Million - $303 Million
-7,302,650 Reduced 67.29%
3,549,564 $154 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $387 Million - $426 Million
10,328,490 Added 1972.12%
10,852,214 $461 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $6.26 Million - $7.14 Million
162,686 Added 45.06%
523,724 $22.9 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $32.7 Million - $39.7 Million
-948,881 Reduced 72.44%
361,038 $15.9 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $30.8 Million - $32.8 Million
-932,652 Reduced 41.59%
1,309,919 $47.5 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $29.6 Million - $34.4 Million
-928,965 Reduced 29.29%
2,242,571 $79.6 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $619,999 - $657,840
18,641 Added 0.59%
3,171,536 $115 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $97.7 Million - $108 Million
3,152,895
3,152,895 $113 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.